{"id":52584,"date":"2025-09-17T14:30:00","date_gmt":"2025-09-17T12:30:00","guid":{"rendered":"https:\/\/campusvygon.com\/global\/?p=52584"},"modified":"2025-09-22T09:10:39","modified_gmt":"2025-09-22T07:10:39","slug":"septic-shock-fluids-vs-early-vasopressors","status":"publish","type":"post","link":"https:\/\/campusvygon.com\/global\/septic-shock-fluids-vs-early-vasopressors\/","title":{"rendered":"Septic shock resuscitation: fluids vs. early vasopressors? 5 practical lessons from CLOVERS and recent evidence"},"content":{"rendered":"\n

Emergency and critical care teams face a recurring dilemma in early septic shock: How much fluid is enough\u2014and when should we start vasopressors?<\/strong> Prolonged hypotension drives organ injury and mortality, but both fluid overload and delayed vasopressors can harm. The Surviving Sepsis Campaign (SSC) historically suggests 30\u202fmL\/kg<\/strong> initial crystalloid, yet that \u201cone\u2011size\u2011fits\u2011all\u201d dose is a weak<\/strong> recommendation and increasingly questioned in favor of individualized resuscitation.1<\/sup><\/p>\n\n\n\n

<\/div>\n\n\n\n

WHAT THE PHYSIOLOGY AND TRIALS TELL US<\/strong><\/h4>\n\n\n\n

Septic shock is predominantly vasoplegic<\/strong>\u2014systemic vasodilation and vascular leak impair perfusion. Mortality remains high (often reported up to ~60% in some settings), and the degree and duration of hypotension<\/strong> are major outcome determinants, making rapid restoration of MAP \u226565<\/strong>\u202f<\/strong>mmHg<\/strong> a core goal (with higher targets for some chronic hypertensives).1<\/sup><\/p>\n\n\n\n

Large early fluid loads have long been used to raise MAP, but dynamic monitoring shows not all patients are fluid responsive<\/strong>; unnecessary fluid increases positive balance, delays organ recovery, prolongs ICU stay, and is associated with higher mortality. Emerging evidence favors earlier norepinephrine<\/strong> (NE) to treat vasodilation, often within the first hour, to correct pressure faster, recruit perfusion, and avoid fluid overload.1<\/sup><\/p>\n\n\n\n

<\/div>\n\n\n\n

THE PROBLEM WITH DOING \u201cFLUIDS FIRST\u201d EVERY TIME<\/strong><\/h4>\n\n\n\n
    \n
  • Over-resuscitation risks:<\/strong> Positive fluid balance correlates with higher mortality and longer stays; the SOAP analysis and other cohorts link fluid overload to worse outcomes.1<\/sup><\/li>\n\n\n\n
  • Variable responsiveness:<\/strong> Static signs (HR, BP) are poor guides; dynamic indices and bedside ultrasound outperform them for predicting fluid responsiveness.1<\/sup><\/li>\n\n\n\n
  • Guideline nuance:<\/strong> SSC\u2019s 30\u202fmL\/kg is not<\/strong> a must for all\u2014especially in cardiac or renal dysfunction; personalization is advised.1<\/sup><\/li>\n<\/ul>\n\n\n\n
    <\/div>\n\n\n\n

    WHAT CLOVERS ADDS\u2014AND WHAT IT DOESN\u2019T<\/strong><\/h4>\n\n\n\n

    The CLOVERS<\/strong> randomized trial compared restrictive<\/strong> (vasopressors earlier, less fluid) versus liberal<\/strong> (more fluid before vasopressors) strategies for the first 24\u202fhours<\/strong> after patients had already received 1\u20133\u202fL<\/strong>. Mortality before discharge home by day 90 was similar<\/strong> (14.0% vs. 14.9%; P<\/em>\u202f=\u202f0.61). The restrictive arm used significantly less fluid<\/strong>, earlier<\/strong> and longer<\/strong> vasopressors, with no safety signal<\/strong> difference overall (including very low rates of peripheral vasopressor complications). Bottom line:<\/strong> Both approaches yielded comparable outcomes in this context, underscoring the need to tailor strategy to patient physiology rather than defaulting to volume alone.2<\/sup><\/p>\n\n\n\n

    Important nuance:<\/strong> CLOVERS does not<\/strong> endorse flooding patients; it shows that after early initial fluids<\/strong>, prioritizing vasopressors or<\/strong> additional fluids for 24\u202fhours produced similar mortality\u2014while confirming the feasibility and safety of earlier vasopressor use<\/strong>, including peripheral<\/strong> starts when central access is not yet available.2<\/sup><\/p>\n\n\n\n

    <\/div>\n\n\n\n

    5 PRACTICAL LESSONS FOR THE FIRST HOURS OF SEPTIC SHOCK<\/strong><\/h4>\n\n\n\n

    1) Treat vasoplegia fast\u2014start norepinephrine early if hypotension persists after a small test bolus<\/strong><\/p>\n\n\n\n

    If MAP remains <65\u202fmmHg after ~5\u201310<\/strong>\u202f<\/strong>mL\/kg<\/strong> or a 300\u2013500\u202fmL bolus, consider early norepinephrine<\/strong> rather than repeating large fluid boluses. Early NE can raise MAP quicker, decrease preload dependency by mobilizing stressed volume, and reduce fluid requirements\u2014benefits linked to better hemodynamics and fewer complications in observational data and trials like CENSER.1<\/sup><\/p>\n\n\n\n

    2) Individualize fluids using dynamic assessment\u2014not static vitals<\/strong><\/p>\n\n\n\n

    Use passive leg raise, stroke volume change, or point\u2011of\u2011care ultrasound (e.g., LV filling, IVC dynamics) to decide if a patient will actually<\/strong> increase cardiac output with more fluid. This reduces the risk of overload without compromising perfusion.1<\/sup><\/p>\n\n\n\n

    3) Don\u2019t delay vasopressors waiting for a central line<\/strong><\/p>\n\n\n\n

    Initiate NE peripherally<\/strong> (appropriately sized IV, vigilant monitoring) when central access is not yet secured. Recent clinical experience shows very low rates of self\u2011limited extravasation when done carefully\u2014supporting earlier correction of hypotension.1,2<\/sup><\/p>\n\n\n\n

    4) Target MAP wisely\u2014and watch diastolic pressure<\/strong><\/p>\n\n\n\n

    Aim for \u226565<\/strong>\u202f<\/strong>mmHg<\/strong> in most, but consider ~80<\/strong>\u202f<\/strong>mmHg<\/strong> in chronic hypertensives or special conditions (e.g., raised ICP, high CVP). A diastolic arterial pressure <60<\/strong>\u202f<\/strong>mmHg<\/strong> or a high Diastolic Shock Index (HR\/DBP >2.2)<\/strong> may flag profound vasoplegia and the need for prompt vasopressors.1<\/sup><\/p>\n\n\n\n

    5) Combine small, mindful boluses with early NE; escalate thoughtfully<\/strong><\/p>\n\n\n\n

    In fluid\u2011responsive patients, small boluses alongside NE can improve mean systemic filling pressure without<\/strong> the harms of large volume loads; if MAP remains inadequate on NE, vasopressin<\/strong> is a reasonable add\u2011on before escalating NE dose further (evidence for mortality benefit remains mixed).1<\/sup><\/p>\n\n\n\n

    \"\"<\/figure>\n\n\n\n
    <\/div>\n\n\n\n

    PUTTING IT TOGETHER: A SIMPLE BEDSIDE ALGORITHM<\/strong><\/h4>\n\n\n\n
      \n
    1. Initial actions (minutes 0\u201315):<\/strong>
      1. Obtain IV access, cultures, antibiotics, lactate, source control as indicated.<\/li><\/ol>\n
          \n
        1. Give an initial 300\u2013500<\/strong>\u202f<\/strong>mL<\/strong> crystalloid bolus while you set up dynamic assessment.1<\/sup><\/li>\n<\/ol>\n<\/li>\n\n\n\n
        2. Assess response (minutes 15\u201330):<\/strong>
          1. If fluid responsive<\/strong>, consider another small bolus<\/strong>; if not responsive<\/strong> or signs of overload, stop fluids<\/strong>.<\/li><\/ol>\n
              \n
            1. If MAP <65\u202fmmHg, start NE<\/strong> (peripheral if needed).1<\/sup><\/li>\n<\/ol>\n<\/li>\n\n\n\n
            2. Stabilize macro\u2011perfusion (first 60 minutes):<\/strong>
              1. Titrate NE to MAP target (often \u226565<\/strong>\u202f<\/strong>mmHg<\/strong>; higher in selected patients).<\/li><\/ol>\n
                  \n
                1. Reassess for fluid responsiveness and signs of congestion after any bolus.1<\/sup><\/li>\n<\/ol>\n<\/li>\n\n\n\n
                2. First 6\u201324<\/strong>\u202f<\/strong>hours:<\/strong>
                  1. Continue personalized<\/strong> fluids only when responsive; avoid automatic \u201c30\u202fmL\/kg.\u201d<\/li><\/ol>
                    1. Add vasopressin<\/strong> if NE requirements rise and perfusion is still inadequate.<\/li><\/ol>\n
                        \n
                      1. Remember: In CLOVERS, a restrictive<\/strong> strategy (more vasopressors, less fluid) did not<\/strong> reduce 90\u2011day mortality vs. a liberal<\/strong> strategy after 1\u20133\u202fL\u2014use clinical judgment and physiology to steer the course.1, 2<\/sup><\/li>\n<\/ol>\n<\/li>\n<\/ol>\n\n\n\n
                        <\/div>\n\n\n\n

                        KEY TAKEAWAYS<\/strong><\/h4>\n\n\n\n
                          \n
                        • Avoid fluid reflexes.<\/strong> Use dynamic tests to decide who benefits from more volume.1<\/sup><\/li>\n\n\n\n
                        • Correct vasoplegia early.<\/strong> Starting norepinephrine<\/strong> sooner can restore MAP faster and curb fluid exposure.1<\/sup><\/li>\n\n\n\n
                        • Safety first.<\/strong> Peripheral NE is acceptable as a bridge; monitor the site closely.1,2<\/sup><\/li>\n\n\n\n
                        • No single recipe.<\/strong> CLOVERS shows both strategies can be safe after early fluids; individualization<\/strong> is the winning principle.2<\/sup><\/li>\n<\/ul>\n\n\n\n

                          Modern septic shock resuscitation is not \u201cfluids first for everyone.\u201d The signal across physiology, trials, and practice is to personalize fluid therapy and adopt early vasopressors when hypotension persists after a small, diagnostic bolus\u2014reducing the risk of fluid overload while restoring perfusion rapidly. CLOVERS reminds us that after an early liter or two, both fluid\u2011forward and vasopressor\u2011forward pathways can achieve similar outcomes\u2014so let patient phenotype and responsiveness<\/strong> guide your next move.1, 2<\/sup><\/p>\n\n\n\n

                          <\/div>\n\n\n\n

                          BIBLIOGRAPHY<\/strong><\/h4>\n\n\n\n
                            \n
                          1. Sanchez CE, Pinsky MR, Sinha S, et<\/strong>\u202f<\/strong>al.<\/strong> Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet? J Crit Care Med.<\/em> 2023;9(3):138\u2011147. doi:10.2478\/jccm-2023-0022. <\/li>\n\n\n\n
                          2. Shapiro NI, Douglas IS, Brower RG, et\u202fal.<\/strong>\u00a0Early Restrictive or Liberal Fluid Management for Sepsis\u2011Induced Hypotension (CLOVERS).\u00a0N Engl J Med.<\/em>\u00a02023;388(6):499\u2011510. (Author manuscript, HHS Public Access). doi:10.1056\/NEJMoa2212663.\u00a0<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                            Emergency and critical care teams face a recurring dilemma in early septic shock: How much fluid is enough\u2014and when should we start vasopressors? Prolonged hypotension drives organ injury and mortality, but both fluid overload and delayed vasopressors can harm. The Surviving Sepsis Campaign (SSC) historically suggests 30\u202fmL\/kg initial crystalloid, yet that \u201cone\u2011size\u2011fits\u2011all\u201d dose is a weak recommendation and increasingly questioned in […]<\/p>\n","protected":false},"author":4,"featured_media":52590,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[919],"tags":[1115,743,1108],"class_list":["post-52584","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-anaesthesia-and-intensive-care","tag-hemodynamic-management","tag-sepsis","tag-septic-shock"],"acf":[],"_links":{"self":[{"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/posts\/52584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/comments?post=52584"}],"version-history":[{"count":6,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/posts\/52584\/revisions"}],"predecessor-version":[{"id":52596,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/posts\/52584\/revisions\/52596"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/media\/52590"}],"wp:attachment":[{"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/media?parent=52584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/categories?post=52584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/campusvygon.com\/global\/wp-json\/wp\/v2\/tags?post=52584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}